BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 9, 2009
View Archived Issues
Preclinical and phase I data on PI3 and mTOR kinase inhibitor GDC-0980 presented
Read More
Lentiviral vector gene therapy for X-linked adrenoleukodystrophy / News in Context
Read More
Selumetinib exhibits modest activity in AML in phase II trial
Read More
CORE trial data suggest efficacy of deferasirox in hereditary hemochromatosis
Read More
AJM-300 shows clinical activity in patients with active Crohn's disease
Read More
Preclinical and early phase I data suggest activity of JI-101 in solid tumors
Read More
Panacea Biotec claims novel compounds for the treatment of bacterial infections
Read More
Novel S1P1/edg1 receptor agonists in early development at Actelion
Read More
Takeda discloses novel ACC inhibitors for the treatment of obesity
Read More
Intellikine describes novel PI3K and mTOR inhibitors for the treatment of cancer
Read More
Novel GK activators claimed by Roche as antidiabetic agents
Read More
Alkermes licenses Medifusion technology platform from Acceleron
Read More
BioAlliance Pharma reports phase II survival data on doxorubicin Transdrug
Read More
Curis reports preclinical data on HSP 90 inhibitor CUDC-305
Read More
Stockholders approve Anesiva merger with Arcion Therapeutics
Read More
FDA approves initiation of clinical studies of Taro's T-2000 in the U.S.
Read More
Neoprobe's Lymphoseek achieves primary endpoint in phase III trial
Read More
Allos Therapeutics forms agreement with Idis for Folotyn
Read More
Janssen-Cilag submits MAA in Europe for paliperidone palmitate for schizophrenia
Read More
Oxygen Biotherapeutics enrolls first patient in Oxycyte trial in traumatic brain injury
Read More
Pharmaxis reports sustained benefit with Bronchitol in phase III trial in cystic fibrosis
Read More
Phase I/II clinical data reported for BiondVax's universal flu vaccine
Read More
Pluristem Therapeutics doses first patients in Europe with placenta-derived cell therapy
Read More
Provectus reports phase II data for PH-10 in psoriasis and atopic dermatitis
Read More
Roche to discontinue development of RG-1507
Read More
Radient receives Korean approval for its in vitro diagnostic cancer test Onko-Sure
Read More